CHR is initiating a new series of communication called "OPINIONs: Independent Voices on Reproductive Endocrinology, Medicine and Society." As the title implies, this series is mostly dedicated to topics of national importance related to the practice of reproductive endocrinology and infertility, but, on occasion, also addresses issues of general medical importance. These "OPINIONs" will reflect CHR's formal viewpoints on contemporary circumstances and, therefore, may change over time. They will be numbered and dated. To point out the importance of constantly evolving knowledge in medicine, should an older OPINION be updated or replaced, reference will be made to that older opinion. As appropriate, some OPINIONs, like our inaugural piece on national outcome reporting of IVF results, published on Monday, June 9, 2014, will be referenced; others will not. We encourage comments and responses, especially if reflective of different opinions. Comments can be directly sent to us through the contact form at the end of each OPINION piece, or emailed to ykizawa@thechr.com. We reserve the right to edit responses before posting but will not post edited responses without the authors' permission. Acceptance of responses is at the full discretion of our editorial division. Considering the large and rapidly increasing number of visitors to CHR's website, we expect this new feature to evolve into a strong independent voice, representing patients' best interests. Stay tuned for this exciting new voice from CHR!

Table of Contents

Each OPINION piece can be accessed from the list below. Future OPINION pieces will be linked from here as they are published.

Fertility Updates

Nothing more controversial than PGS

-+*OPINIONs 010: June 6, 2017  Summary A new form of preimplantation genetic screening (PGS), named “preimplantation genetic diagnosis for aneuploidy screening (PGD-AS)” … Read more